ABSTRACT
Background Long COVID, characterized by persistent symptoms post-COVID-19, presents challenges like reduced functional capacity, pulmonary function, and dyspnea. Telerehabilitation, a remote healthcare approach, is gaining attention for its potential to address these issues
Objectives The study aims to determine the effect of telerehabilitation on functional capacity by six-minute walk test (MWT), pulmonary function by pulmonary function test (PFT), dyspnea by modified medical research council (mMRC) and level of physical activity by Global physical activity questionnaire (GPAQ) in individuals with long COVID.
Materials and Methods At Al Ain Hospital, UAE, a 6-week telerehabilitation program for Long COVID patients aged 18-75 was studied using single-group pretest-posttest quasi-experimental design. Pre and post assessments included 6MWT, PFT, mMRC, and GPAQ. The study also monitored technical issues and session adherence.
Results Participants had an average age of 49.30 ± 15.46, height of 163.80 ± 9.76, and weight of 78.70 ± 15.58, with a gender ratio of 12 females to 8 males. After six weeks of telerehabilitation, significant improvements were seen in the 6MWT (21% improvement) and PFT (4% FVC increase, 8% FEV1 increase, 1% FEV1/FVC increase, and 11% PEF increase). mMRC scale scores post-rehabilitation were significantly lower, indicating substantial improvement in dyspnea levels with clinical significance.
Conclusion This approach has shown tangible benefits in enhancing functional capacity, pulmonary function, reducing dyspnea, and improving physical activity levels among individuals with Long COVID. The results of the study demonstrate the feasibility and effectiveness of implementing a telerehabilitation program for individuals with Long
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained Institutional Review Board (Ref. no. (IRB/COHS/STD/04/Jan-2022) of Gulf Medical University and SEHA, Al Ain hospital (Ref no. ERC-19022-1-2022).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
